The Genomics Wave Is Changing Drug Discovery and Development

September 16, 2016

ABC2 CEO Max Wallace told The Washington Post on Wednesday that advancements in genomic technologies are changing the way drugs are discovered and developed. "We're very interested in the genomic sequencing and function data that's coming out," Wallace said, "People would consider brain cancer a relatively small market cancer with not a lot of funding going into it compared to some of the bigger ones.  But now that we're seeing it's not brain cancer, it's not liver cancer, it's not breast cancer, it's a cancer of a particular construct, it means we can look for pathways common among a range of cancers and steal all the best drugs that are being discovered in those higher-marketed cancers."

Click HERE to view the Transformers: Medicine event on Washington Post Live.